STOKE THERAPEUTICS INC (STOK) Stock Analyst Earnings Estimates
NASDAQ:STOK - Nasdaq - US86150R1077 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.41M | 8.78M -29.25% | 18.036M 105.42% | 20.765M 15.13% | 24.909M 19.96% | 60.501M 142.89% | 110.79M 83.12% | 292.91M 164.38% | 548.4M 87.22% | 782.81M 42.74% | 1.033B 31.96% | ||
| EBITDA YoY % growth | -85.1M -63.18% | -102.81M -20.81% | -112.304M -9.23% | -121.482M -8.17% | -143.576M -18.19% | -159.377M -11.01% | -49.403M 69.00% | -36.9M 25.31% | 101.33M 374.61% | 333.27M 228.90% | 595.3M 78.62% | 868.08M 45.82% | |
| EBIT YoY % growth | -86.07M -62.27% | -104.36M -21.25% | -114.773M -9.98% | -122.73M -6.93% | -152.754M -24.46% | -184.132M -20.54% | -117.803M 36.02% | -121.893M -3.47% | 75.725M 162.12% | 262.65M 246.85% | 450.98M 71.70% | 644.36M 42.88% | |
| Operating Margin | N/A | -840.93% | -1,307.21% | -680.47% | -735.63% | -739.22% | -194.71% | -110.02% | 25.85% | 47.89% | 57.61% | 62.38% | |
| EPS YoY % growth | -2.33 -49.36% | -2.60 -11.59% | -2.37 8.69% | -2.06 13.30% | -2.17 -5.23% | -2.72 -25.56% | -1.67 38.49% | -1.49 10.85% | 1.93 229.62% | 4.11 112.66% | 5.91 43.80% | 7.72 30.63% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 8.37% | -0.60 -4.42% | -0.47 -2.85% | -0.65 -39.15% | -0.59 -6.53% |
| Revenue Q2Q % growth | 4.284M 52.95% | 3.121M -25.97% | 13.321M 175.74% | 2.917M -40.40% | 10.277M 139.89% |
| EBITDA Q2Q % growth | -30.151M -11.19% | -35.013M -25.91% | -33.216M -17.66% | -36.266M -27.91% | -21.21M 29.65% |
| EBIT Q2Q % growth | -32.896M -11.19% | -37.94M -33.72% | -40.21M -37.04% | -43.354M -44.50% | -37.782M -14.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.47 15.16% | -0.54 | 0.07 | 13.51% |
| Q2 2024 Q2Q % growth | -0.46 33.33% | -0.57 | 0.11 | 19.47% |
| Q1 2024 Q2Q % growth | -0.57 -7.55% | -0.62 | 0.05 | 8.39% |
| Q4 2023 Q2Q % growth | -0.60 7.69% | -0.64 | 0.04 | 6.63% |
| Q3 2023 Q2Q % growth | -0.55 16.06% | -0.65 | 0.09 | 14.13% |
| Q2 2023 Q2Q % growth | -0.69 -9.52% | -0.65 | -0.04 | -6.31% |
| Q1 2023 Q2Q % growth | -0.53 19.70% | -0.71 | 0.18 | 25.38% |
| Q4 2022 Q2Q % growth | -0.65 1.52% | -0.72 | 0.07 | 9.22% |
| Q3 2022 Q2Q % growth | -0.66 -8.20% | -0.70 | 0.04 | 5.40% |
| Q2 2022 Q2Q % growth | -0.63 -5.00% | -0.70 | 0.07 | 10.20% |
| Q1 2022 Q2Q % growth | -0.66 -43.48% | 0.37 | -1.03 | -278.64% |
| Q4 2021 Q2Q % growth | -0.66 -57.14% | -0.64 | -0.02 | -3.86% |
| Q3 2021 Q2Q % growth | -0.61 -48.78% | -0.60 | -0.01 | -1.75% |
| Q2 2021 Q2Q % growth | -0.60 -53.85% | -0.48 | -0.12 | -25.16% |
| Q1 2021 Q2Q % growth | -0.46 -35.29% | -0.45 | -0.01 | -2.50% |
| Q4 2020 Q2Q % growth | -0.42 -366.67% | -0.43 | 0.01 | 1.73% |
| Q3 2020 Q2Q % growth | -0.41 -57.69% | -0.42 | 0.01 | 2.96% |
| Q2 2020 Q2Q % growth | -0.39 74.68% | -0.36 | -0.03 | -7.81% |
| Q1 2020 Q2Q % growth | -0.34 | -0.36 | 0.02 | 6.40% |
| Q4 2019 Q2Q % growth | -0.09 | -0.32 | 0.23 | 71.76% |
| Q3 2019 Q2Q % growth | -0.26 | -0.28 | 0.02 | 6.70% |
| Q2 2019 Q2Q % growth | -1.54 | -0.98 | -0.56 | -57.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.894M 47.94% | 3.417M | 1.477M | 43.23% |
| Q2 2024 Q2Q % growth | 4.831M 294.72% | 3.321M | 1.51M | 45.47% |
| Q1 2024 Q2Q % growth | 4.216M -18.17% | 3.279M | 937K | 28.58% |
| Q4 2023 Q2Q % growth | 2.801M -14.34% | 3.315M | -514K | -15.51% |
| Q3 2023 Q2Q % growth | 3.308M 13.68% | 3.251M | 57K | 1.75% |
| Q2 2023 Q2Q % growth | -2.481M -176.81% | 3.162M | -5.643M | -178.46% |
| Q1 2023 Q2Q % growth | 5.152M 71.73% | 2.678M | 2.474M | 92.38% |
| Q4 2022 Q2Q % growth | 3.27M | 2.628M | 642K | 24.43% |
| Q3 2022 Q2Q % growth | 2.91M | 2.499M | 411K | 16.45% |
| Q2 2022 Q2Q % growth | 3.23M | 2.394M | 836K | 34.92% |
| Q1 2022 Q2Q % growth | 3M | 40.8M | -37.8M | -92.65% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.87% | 2.98% | 1.02% | 2.14% |
| Revenue | 16.67% | 26.86% | 0% | 7.17% |